Scientific Publications Search Search Author Impact Factor Release Date Research Group Search Sort by RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Order AscDesc Akalin, Altuna Dr. (1) Berruezo Llacuna, Maria (1) Blankenstein, Thomas Prof. Dr. (3) Bunse, Mario Dr. (3) Caganova, Marieta Dr. (1) Chen, Wei Prof. Dr. (2) Daumke, Oliver Prof. Dr. (2) Dittmar, Gunnar Dr. (1) Di Virgilio, Michela Prof. Dr. (1) Driesner, Madlen (1) Edes, Inan Dr. (1) Fälber, Katja Dr. (1) Graf, Robin Dr. (2) Hammes-Lewin, Annette Dr. (1) Heinemann, Udo Prof. Dr. (1) Hirsekorn, Antje (1) Höpken, Uta Elisabeth PD Dr. (1) Hübner, Norbert Prof. Dr. (1) Ivics, Zoltan Dr. (1) Izsvak, Zsuzsanna Dr. (2) Janz, Martin Dr. (9) Kammertöns, Thomas Dr. (3) Kärgel, Eva Dr. (1) Keller, Lisa (1) Keller, Ulrich Dr. med. (2) Kettenmann, Helmut Prof. Dr. (1) Klußmann, Enno PD Dr. (1) Kocks, Christine Dr. (1) Ku, Min-Chi Dr. (1) Landthaler, Markus Prof. Dr. (3) Leutz, Achim Prof. Dr. (1) Lewin, Gary Prof. Dr. (1) Lorenz, Felix Dr. (1) Menzel, Lutz Peter Dr. (1) Mertins, Philipp Dr. (1) Milek, Miha Dr. (1) Niendorf, Thoralf Prof. Dr. (1) Obermayer, Benedikt Dr. (1) Ohler, Uwe Prof. Dr. (2) Panakova, Daniela Dr. (1) Patone, Giannino Dr. (1) Pezzutto, Antonio Prof. Dr. (1) Popp, Oliver Dr. (1) Prigione, Alessandro Prof. Dr. (1) Rahjouei, Ali Dr. (1) Rajewsky, Klaus Prof. Dr. (2) Rehm, Armin Dr. (1) Rhein, Simone Dr. (1) Rocks, Oliver Dr. (2) Roske, Yvette Dr. (1) Scheidereit, Claus Prof. Dr. (1) Schlag, Peter M. Prof. Dr. (1) Selbach, Matthias Prof. Dr. (17) Uckert, Wolfgang Prof. Dr. (21) Waiczies, Helmar Dr. (1) Waiczies, Sonia Dr. (1) Wanker, Erich Prof. Dr. (1) Willnow, Thomas Prof. Dr. (1) Wolf, Susanne Dr. (1) Wyler, Emanuel Dr. (1) Zauber, Henrik Dr. (4) Zühlke, Kerstin Dr. (1) (-) Leisegang, Matthias Dr. (2) (-) Mathas, Stephan Dr. (9) 1999 (1) 2000 (1) 2001 (1) 2002 (5) 2003 (1) (-) 2004 (2) 2005 (2) 2006 (5) (-) 2007 (3) 2008 (5) 2009 (3) 2010 (7) 2011 (5) 2012 (4) 2013 (1) 2014 (4) 2015 (8) (-) 2016 (4) 2017 (5) 2018 (1) 2019 (2) (-) 2020 (2) 2021 (3) 2022 (4) (-) Biology of Malignant Lymphomas (9) Genetics and Genomics of Cardiovascular Diseases (1) Mechanism-based Cancer Therapies (2) (-) Molecular Cell Biology and Gene Therapy (2) Molecular Immunology and Gene Therapy (2) Signal Transduction in Tumor Cells (1) 11 Results: Active Filter: Leisegang, Matthias Dr.Mathas, Stephan Dr.Biology of Malignant LymphomasMolecular Cell Biology and Gene Therapy2004200720162020 Sort: Result score Newest to oldest Oldest to newest December 17, 2020 in Blood Tumor and microenvironment response but no cytotoxic T-cell activation in classic Hodgkin lymphoma treated with anti-PD1 S. Reinke P.J. Bröckelmann I. Iaccarino M. Garcia-Marquez S. Borchmann F. Jochims M. Kotrova K. Pal M. Brüggemann E. Hartmann S. Sasse C. Kobe S. Mathas M. Soekler U. Keller M. Bormann A. Zimmermann J. Richter M. Fuchs B. von Tresckow P. Borchmann H. Schlößer M. von Bergwelt-Baildon A. Rosenwald A. Engert W. Klapper June 01, 2020 in JAMA Oncol Efficacy of nivolumab and AVD in early-stage unfavorable classic Hodgkin lymphoma: the randomized phase 2 German Hodgkin Study Group NIVAHL trial P.J. Bröckelmann H. Goergen U. Keller J. Meissner R. Ordemann T.V. Halbsguth S. Sasse M. Sökler A. Kerkhoff S. Mathas A. Hüttmann M. Bormann A. Zimmermann J. Mettler M. Fuchs B. von Tresckow C. Baues A. Rosenwald W. Klapper C. Kobe P. Borchmann A. Engert July 01, 2016 in Semin Hematol Hodgkin lymphoma: pathology and biology S. Mathas S. Hartmann R. Küppers June 01, 2016 in Clin Cancer Res Eradication of large solid tumors by gene therapy with a T cell receptor targeting a single cancer-specific point mutation M. Leisegang B. Engels K. Schreiber P.Y. Yew K. Kiyotani C. Idel A. Arina J. Duraiswamy R.R. Weichselbaum W. Uckert Y. Nakamura H. Schreiber March 17, 2016 in Genome Med A roadmap of constitutive NF-κB activity in Hodgkin lymphoma: dominant roles of p50 and p52 revealed by genome-wide analyses K.A.P. de Oliveira E. Kaergel M. Heinig J.F. Fontaine G. Patone E.M. Muro S. Mathas M. Hummel M.A. Andrade-Navarro N. Hübner C. Scheidereit March 01, 2016 in J Clin Invest Targeting human melanoma neoantigens by T cell receptor gene therapy M. Leisegang T. Kammertoens W. Uckert T. Blankenstein October 01, 2007 in Hematol Oncol Clin North Am The pathogenesis of classical Hodgkin's lymphoma: a model for B-cell plasticity S. Mathas May 01, 2007 in Br J Haematol Loss of bHLH transcription factor E2A activity in primary effusion lymphoma confers resistance to apoptosis A. Lietz M. Janz M. Sigvardsson F. Jundt B. Doerken S. Mathas March 01, 2007 in Hum Immunol Dendritic cell maturation stage determines susceptibility to the proteasome inhibitor bortezomib M. Subklewe K. Sebelin-Wulf C. Beier A. Lietz S. Mathas B. Doerken A. Pezzutto April 19, 2004 in J Exp Med c-FLIP mediates resistance of Hodgkin/Reed-Sternberg cells to death receptor-induced apoptosis S. Mathas A. Lietz I. Anagnostopoulos F. Hummel B. Wiesner M. Janz F. Jundt B. Hirsch K. Joehrens-Leder H.P. Vornlocher K. Bommert H. Stein B. Doerken Pagination Current page 1 Page 2 Next page Next › Last page Last »
December 17, 2020 in Blood Tumor and microenvironment response but no cytotoxic T-cell activation in classic Hodgkin lymphoma treated with anti-PD1 S. Reinke P.J. Bröckelmann I. Iaccarino M. Garcia-Marquez S. Borchmann F. Jochims M. Kotrova K. Pal M. Brüggemann E. Hartmann S. Sasse C. Kobe S. Mathas M. Soekler U. Keller M. Bormann A. Zimmermann J. Richter M. Fuchs B. von Tresckow P. Borchmann H. Schlößer M. von Bergwelt-Baildon A. Rosenwald A. Engert W. Klapper
June 01, 2020 in JAMA Oncol Efficacy of nivolumab and AVD in early-stage unfavorable classic Hodgkin lymphoma: the randomized phase 2 German Hodgkin Study Group NIVAHL trial P.J. Bröckelmann H. Goergen U. Keller J. Meissner R. Ordemann T.V. Halbsguth S. Sasse M. Sökler A. Kerkhoff S. Mathas A. Hüttmann M. Bormann A. Zimmermann J. Mettler M. Fuchs B. von Tresckow C. Baues A. Rosenwald W. Klapper C. Kobe P. Borchmann A. Engert
July 01, 2016 in Semin Hematol Hodgkin lymphoma: pathology and biology S. Mathas S. Hartmann R. Küppers
June 01, 2016 in Clin Cancer Res Eradication of large solid tumors by gene therapy with a T cell receptor targeting a single cancer-specific point mutation M. Leisegang B. Engels K. Schreiber P.Y. Yew K. Kiyotani C. Idel A. Arina J. Duraiswamy R.R. Weichselbaum W. Uckert Y. Nakamura H. Schreiber
March 17, 2016 in Genome Med A roadmap of constitutive NF-κB activity in Hodgkin lymphoma: dominant roles of p50 and p52 revealed by genome-wide analyses K.A.P. de Oliveira E. Kaergel M. Heinig J.F. Fontaine G. Patone E.M. Muro S. Mathas M. Hummel M.A. Andrade-Navarro N. Hübner C. Scheidereit
March 01, 2016 in J Clin Invest Targeting human melanoma neoantigens by T cell receptor gene therapy M. Leisegang T. Kammertoens W. Uckert T. Blankenstein
October 01, 2007 in Hematol Oncol Clin North Am The pathogenesis of classical Hodgkin's lymphoma: a model for B-cell plasticity S. Mathas
May 01, 2007 in Br J Haematol Loss of bHLH transcription factor E2A activity in primary effusion lymphoma confers resistance to apoptosis A. Lietz M. Janz M. Sigvardsson F. Jundt B. Doerken S. Mathas
March 01, 2007 in Hum Immunol Dendritic cell maturation stage determines susceptibility to the proteasome inhibitor bortezomib M. Subklewe K. Sebelin-Wulf C. Beier A. Lietz S. Mathas B. Doerken A. Pezzutto
April 19, 2004 in J Exp Med c-FLIP mediates resistance of Hodgkin/Reed-Sternberg cells to death receptor-induced apoptosis S. Mathas A. Lietz I. Anagnostopoulos F. Hummel B. Wiesner M. Janz F. Jundt B. Hirsch K. Joehrens-Leder H.P. Vornlocher K. Bommert H. Stein B. Doerken
